TY - JOUR
T1 - COPD phenotypes and machine learning cluster analysis
T2 - A systematic review and future research agenda
AU - Nikolaou, Vasilis
AU - Massaro, Sebastiano
AU - Fakhimi, Masoud
AU - Stergioulas, Lampros
AU - Price, David
N1 - Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or ot-for-profit sectors.
PY - 2020/9
Y1 - 2020/9
N2 - Chronic Obstructive Pulmonary Disease (COPD) is a highly heterogeneous condition projected to become the third leading cause of death worldwide by 2030. To better characterize this condition, clinicians have classified patients sharing certain symptomatic characteristics, such as symptom intensity and history of exacerbations, into distinct phenotypes. In recent years, the growing use of machine learning algorithms, and cluster analysis in particular, has promised to advance this classification through the integration of additional patient characteristics, including comorbidities, biomarkers, and genomic information. This combination would allow researchers to more reliably identify new COPD phenotypes, as well as better characterize existing ones, with the aim of improving diagnosis and developing novel treatments. Here, we systematically review the last decade of research progress, which uses cluster analysis to identify COPD phenotypes. Collectively, we provide a systematized account of the extant evidence, describe the strengths and weaknesses of the main methods used, identify gaps in the literature, and suggest recommendations for future research
AB - Chronic Obstructive Pulmonary Disease (COPD) is a highly heterogeneous condition projected to become the third leading cause of death worldwide by 2030. To better characterize this condition, clinicians have classified patients sharing certain symptomatic characteristics, such as symptom intensity and history of exacerbations, into distinct phenotypes. In recent years, the growing use of machine learning algorithms, and cluster analysis in particular, has promised to advance this classification through the integration of additional patient characteristics, including comorbidities, biomarkers, and genomic information. This combination would allow researchers to more reliably identify new COPD phenotypes, as well as better characterize existing ones, with the aim of improving diagnosis and developing novel treatments. Here, we systematically review the last decade of research progress, which uses cluster analysis to identify COPD phenotypes. Collectively, we provide a systematized account of the extant evidence, describe the strengths and weaknesses of the main methods used, identify gaps in the literature, and suggest recommendations for future research
KW - chronic respiratory disease
KW - subtypes
KW - statistical analysis
KW - Statistical analysis
KW - Chronic respiratory disease
KW - Subtypes
KW - SUBTYPES
KW - CLINICAL PHENOTYPES
KW - AIRWAYS DISEASE
KW - IDENTIFICATION
KW - MILD
KW - OBSTRUCTIVE PULMONARY-DISEASE
KW - DOUBLE-BLIND
KW - EXACERBATIONS
KW - LUNG-DISEASE
KW - ASTHMA
UR - http://www.scopus.com/inward/record.url?scp=85088944423&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2020.106093
DO - 10.1016/j.rmed.2020.106093
M3 - Article
C2 - 32745966
VL - 171
SP - 106093
JO - Respiratory Medicine
JF - Respiratory Medicine
SN - 0954-6111
M1 - 106093
ER -